Nigeria approves malaria vaccine after Ghana
Every year, the illness claims the lives of around 6,000 people worldwide, many of them children in Sub-Saharan Africa.
Boakyewaa Lawrencia 
A new malaria vaccine created by researchers at Oxford University has been authorized by Nigeria.
After Ghana became the first nation in the world to authorize the (R21) vaccination, the action was taken shortly after.
Mojisola Adeyeye, the director-general of Nigeria's National Agency for Food and Drug Administration, stated that the vaccine would be used to prevent malaria in children between the ages of five months and three years, who are the most vulnerable population.
The approval is rare because it occurs before the vaccine's final stage trial results, which are anticipated to show an effectiveness of 80%, are released.
The majority of malaria deaths worldwide occur in Nigeria.
